These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 1912555

  • 1. Prolonged, continuous treatment of hairy cell leukemia patients with recombinant interferon-alpha 2a.
    Smith JW, Longo DL, Urba WJ, Clark JW, Watson T, Beveridge J, Conlon KC, Sznol M, Creekmore SP, Alvord WG.
    Blood; 1991 Oct 01; 78(7):1664-71. PubMed ID: 1912555
    [Abstract] [Full Text] [Related]

  • 2. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.
    Glaspy JA, Souza L, Scates S, Narachi M, Blatt L, Ambersley J, Golde DW.
    J Immunother (1991); 1992 Apr 01; 11(3):198-208. PubMed ID: 1381218
    [Abstract] [Full Text] [Related]

  • 3. Long-term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian Cooperative Group for HCL.
    Federico M, Frassoldati A, Lamparelli T, Foà R, Brugiatelli M, Annino L, Baldini L, Capnist G, Chisesi T, di Celle PF.
    Ann Oncol; 1994 Oct 01; 5(8):725-31. PubMed ID: 7826905
    [Abstract] [Full Text] [Related]

  • 4. Treatment of hairy cell leukemia with alternating cycles of pentostatin and recombinant leukocyte A interferon: results of a phase II study.
    Martin A, Nerenstone S, Urba WJ, Longo DL, Lawrence JB, Clark JW, Hawkins MJ, Creekmore SP, Smith JW, Steis RG.
    J Clin Oncol; 1990 Apr 01; 8(4):721-30. PubMed ID: 2313337
    [Abstract] [Full Text] [Related]

  • 5. Incidence of response and long-term follow-up in patients with hairy cell leukemia treated with recombinant interferon alfa-2a.
    Berman E, Heller G, Kempin S, Gee T, Tran LL, Clarkson B.
    Blood; 1990 Feb 15; 75(4):839-45. PubMed ID: 2302457
    [Abstract] [Full Text] [Related]

  • 6. Recombinant interferon-alpha-2b treatment of hairy-cell leukaemia: experience with a low-dose schedule.
    Hasselbalch H, Braide I, Lisse I, Röckert LL, Swolin B, Carneskog J, Hagberg H, Hippe E, Jensen MK, Lundin P.
    Eur J Haematol; 1988 Nov 15; 41(5):438-44. PubMed ID: 3061836
    [Abstract] [Full Text] [Related]

  • 7. Serum soluble interleukin-2 receptor levels in hairy cell leukemia: correlation with clinical and hematological parameters and with alpha-interferon treatment.
    Lauria F, Rondelli D, Raspadori D, Zinzani PL, Benfenati D, Pileri S, Sabattini E, Tura S.
    Leuk Lymphoma; 1992 May 15; 7(1-2):103-7. PubMed ID: 1472920
    [Abstract] [Full Text] [Related]

  • 8. A randomized comparison of two doses of human lymphoblastoid interferon-alpha in hairy cell leukemia. Wellcome HCL Study Group.
    Smalley RV, Anderson SA, Tuttle RL, Connors J, Thurmond LM, Huang A, Castle K, Magers C, Whisnant JK.
    Blood; 1991 Dec 15; 78(12):3133-41. PubMed ID: 1742480
    [Abstract] [Full Text] [Related]

  • 9. Sequential administration of recombinant interferon alpha and deoxycoformycin in the treatment of hairy cell leukaemia.
    Habermann TM, Andersen JW, Cassileth PA, Bennett JM, Oken MM.
    Br J Haematol; 1992 Apr 15; 80(4):466-71. PubMed ID: 1581231
    [Abstract] [Full Text] [Related]

  • 10. Long term results of interferon treatment in hairy cell leukemia. Italian Cooperative Group of Hairy Cell Leukemia (ICGHCL).
    Capnist G, Federico M, Chisesi T, Resegotti L, Lamparelli T, Fabris P, Rossi G, Invernizzi R, Guarnaccia C, Leoni P.
    Leuk Lymphoma; 1994 Aug 15; 14(5-6):457-64. PubMed ID: 7812205
    [Abstract] [Full Text] [Related]

  • 11. Low-dose interferon alfa-2b in the treatment of hairy cell leukemia.
    Moormeier JA, Ratain MJ, Westbrook CA, Vardiman JW, Daly KM, Golomb HM.
    J Natl Cancer Inst; 1989 Aug 02; 81(15):1172-4. PubMed ID: 2746669
    [Abstract] [Full Text] [Related]

  • 12. Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients.
    Golomb HM, Jacobs A, Fefer A, Ozer H, Thompson J, Portlock C, Ratain M, Golde D, Vardiman J, Burke JS.
    J Clin Oncol; 1986 Jun 02; 4(6):900-5. PubMed ID: 3519880
    [Abstract] [Full Text] [Related]

  • 13. Effective natural interferon-alpha therapy in recombinant interferon-alpha-resistant patients with hairy cell leukemia.
    von Wussow P, Pralle H, Hochkeppel HK, Jakschies D, Sonnen S, Schmidt H, Müller-Rosenau D, Franke M, Haferlach T, Zwingers T.
    Blood; 1991 Jul 01; 78(1):38-43. PubMed ID: 2070058
    [Abstract] [Full Text] [Related]

  • 14. Three years' continuous low-dose interferon-alpha treatment of hairy-cell leukaemia: evaluation of response and maintenance dose.
    Nielsen B, Braide I.
    Eur J Haematol; 1992 Oct 01; 49(4):174-9. PubMed ID: 1343089
    [Abstract] [Full Text] [Related]

  • 15. A phase I/II study of recombinant interferon alpha 2a and hydroxyurea for chronic myelocytic leukemia.
    Anger B, Porzsolt F, Leichtle R, Heinze B, Bartram C, Heimpel H.
    Blut; 1989 Jun 01; 58(6):275-8. PubMed ID: 2736308
    [Abstract] [Full Text] [Related]

  • 16. Treatment of hairy cell leukemia with increasing doses of recombinant alpha A interferon.
    Holmes R, Schwarz MA, Whiteside MG, Firkin FC.
    Aust N Z J Med; 1988 Jun 01; 18(4):557-62. PubMed ID: 3196242
    [Abstract] [Full Text] [Related]

  • 17. The alpha 2 (r) interferon in the treatment of hairy cell leukemia: progressive report of 25 cases.
    Mandelli F, Cafolla A, Annino L, Amadori S, Gentile A, Bianco P, Dianzani F.
    J Biol Regul Homeost Agents; 1987 Jun 01; 1(4):177-82. PubMed ID: 3332545
    [Abstract] [Full Text] [Related]

  • 18. Long-term therapeutic efficacy and toxicity of recombinant interferon-alpha 2a in polycythaemia vera.
    Foa P, Massaro P, Caldiera S, LaTargia ML, Iurlo A, Clerici C, Fornier M, Bertoni F, Maiolo AT.
    Eur J Haematol; 1998 May 01; 60(5):273-7. PubMed ID: 9654155
    [Abstract] [Full Text] [Related]

  • 19. Sequential evaluation of alpha-2b-interferon treatment in 128 patients with hairy cell leukemia.
    Golomb HM, Fefer A, Golde DW, Ozer H, Portlock C, Silber R, Rappeport J, Ratain MJ, Thompson J, Bonnem EM.
    Semin Oncol; 1987 Jun 01; 14(2 Suppl 2):13-7. PubMed ID: 3589701
    [Abstract] [Full Text] [Related]

  • 20. Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment.
    Bastie JN, Cazals-Hatem D, Daniel MT, D'Agay MF, Rabian C, Glaisner S, Noel-Walter MP, Dabout D, Flandrin G, Dombret H, Poisson D, Degos L, Castaigne S.
    Leuk Lymphoma; 1999 Nov 01; 35(5-6):555-65. PubMed ID: 10609793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.